Lam S - Search Results

1

Correction: Ono, S.; Lam, S.; Nagahara, M.; Hoon, D.S.B. Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays. J. Clin. Med. 2015, 4, 1890-1907.

Ono S, Lam S, Nagahara M, Hoon DS. Ono S, et al. Among authors: lam s. J Clin Med. 2016 Sep 12;5(9):81. doi: 10.3390/jcm5090081. J Clin Med. 2016. PMID: 27626450 Free PMC article.

2

Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays.

Ono S, Lam S, Nagahara M, Hoon DS. Ono S, et al. Among authors: lam s. J Clin Med. 2015 Oct 23;4(10):1890-907. doi: 10.3390/jcm4101890. J Clin Med. 2015. PMID: 26512704 Free PMC article. Review.

3

Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients.

Kiyohara E, Hata K, Lam S, Hoon DS. Kiyohara E, et al. Among authors: lam s. Methods Mol Biol. 2014;1102:513-22. doi: 10.1007/978-1-62703-727-3_27. Methods Mol Biol. 2014. PMID: 24258996

4

A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients.

Ono S, Oyama T, Lam S, Chong K, Foshag LJ, Hoon DS. Ono S, et al. Among authors: lam s. Oncotarget. 2015 Mar 30;6(9):7053-64. doi: 10.18632/oncotarget.3142. Oncotarget. 2015. PMID: 25749524 Free PMC article. Clinical Trial.

5

Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.

Iida Y, Ciechanover A, Marzese DM, Hata K, Bustos M, Ono S, Wang J, Salomon MP, Tran K, Lam S, Hsu S, Nelson N, Kravtsova-Ivantsiv Y, Mills GB, Davies MA, Hoon DSB. Iida Y, et al. Among authors: lam s. Clin Cancer Res. 2017 Aug 15;23(16):4831-4842. doi: 10.1158/1078-0432.CCR-17-0146. Epub 2017 Apr 7. Clin Cancer Res. 2017. PMID: 28389511 Free PMC article.

6

Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy.

Lin SY, Chang SC, Lam S, Irene Ramos R, Tran K, Ohe S, Salomon MP, Bhagat AAS, Teck Lim C, Fischer TD, Foshag LJ, Boley CL, O'Day SJ, Hoon DSB. Lin SY, et al. Among authors: lam s. Clin Chem. 2020 Jan 1;66(1):169-177. doi: 10.1373/clinchem.2019.307140. Clin Chem. 2020. PMID: 31672856 Free PMC article.

7

Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ, Hoon DS. Kim J, et al. Among authors: lam st. J Clin Oncol. 2005 Apr 20;23(12):2744-53. doi: 10.1200/JCO.2005.07.078. J Clin Oncol. 2005. PMID: 15837989

8

RASAL2 activates RAC1 to promote triple-negative breast cancer progression.

Feng M, Bao Y, Li Z, Li J, Gong M, Lam S, Wang J, Marzese DM, Donovan N, Tan EY, Hoon DS, Yu Q. Feng M, et al. Among authors: lam s. J Clin Invest. 2014 Dec;124(12):5291-304. doi: 10.1172/JCI76711. Epub 2014 Nov 10. J Clin Invest. 2014. PMID: 25384218 Free PMC article. Clinical Trial.

9

False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathology.

Karim RZ, Scolyer RA, Li W, Yee VS, McKinnon JG, Li LX, Uren RF, Lam S, Beavis A, Dawson M, Doble P, Hoon DS, Thompson JF. Karim RZ, et al. Among authors: lam s. Ann Surg. 2008 Jun;247(6):1003-10. doi: 10.1097/SLA.0b013e3181724f5e. Ann Surg. 2008. PMID: 18520228

10

Sacrococcygeal chordoma with spontaneous regression due to a large hemorrhagic component.

González TMC, Lam SW, van der Wal R, Navas A, van Langevelde K. González TMC, et al. Among authors: lam sw. Skeletal Radiol. 2024 May 13. doi: 10.1007/s00256-024-04700-9. Online ahead of print. Skeletal Radiol. 2024. PMID: 38735895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,116 results

Search Page